Why CAR T-cell immunotherapy is such a big deal for cancer treatment

The FDA will likely approve the gene-altering therapy. A new immunotherapy treatment has been recommended for approval by the FDA. It would be the first genetically-modified therapy to reach market. Pixabay Yesterday, the Food and Drug Administration recommended a brand new type of cancer treatment for approval: One that employs the body’s immune system—a method known…

Leave a Reply

Your email address will not be published. Required fields are marked *

9 + 3 =